Hard to determine what a fair price is, given the OCP stranglehold (both equity and debt) and resulting deterrent to would be acquirers.
There should be re-rating potential on the Q1 CY19 resource upgrade, hopefully before next CR.
AML Price at posting:
27.5¢ Sentiment: Buy Disclosure: Not Held